The Genotype-phenotype Correlation of HLA-DQ2 and HLA-DQ8 Haplotypes in Pediatric Celiac Disease: A Single Center Experience

Year 2023, Volume: 24 Issue: 3, 220 - 225, 30.09.2023

Didem Gülcü Taşkın Özlem Anlaş

Abstract

Objective: Celiac disease (CD) is a multifactorial disease caused by the interaction of HLA-DQA1 and HLA-DQB1 alleles, which are known to be associated with disease susceptibility in addition to gliadin and other environmental factors. The aim of this study was to determine the incidence of genetic alleles in pediatric CD at our center.
Materials and Methods: This study was designed as a retrospective evaluation of the clinical and genetic findings of patients followed up with a diagnosis of CD in the Pediatric Gastroenterology Outpatient Clinic. According to the study; the data of age, compliance with the diet, family history of disease, genetic testing outcomes, and Marsh classification were compared.
Results: A total of 138 CD patients (94 female, 44 male) were included in our study. The most frequent genetic allele was HLA-DQ2 (69.6%). There was no significant relationship between genetic results and gender, age at diagnosis, body mass index, monthly growth rate, and compliance with diet. In addition, no relationship was found between the genetic structure of the patients and their positive family history with CD. In our study, type 1 diabetes mellitus (DM) was the most frequent disease accompanying CD. Remarkably, higher concomitant positivity of DQ2(+) and DQ8(+) was found in patients presenting with CD and type 1 DM coexistence.
Conclusion: Genetic tests are used for the exclusion of CD disease, rather than diagnosis of. The importance of genetic testing to reduce interventional procedures for CD must be acknowledged.

Keywords

Pediatric, celiac disease, genetic mutations, HLA-DQ2, HLA-DQ8

References

• 1. Rostami-Nejad M, Romanos J, Rostami K, Ganji A, Ehsani-Ardakani MJ, Bakhshipour AR, et al. Allele and haplotype frequencies for HLA-DQ in Iranian celiac disease patient. World J Gastroenterol 2014; 20: 6302-8.
• 2. Dieli-Crimi R, Cénit MC, Núñez C. The genetics of celiac disease: A comprehensive review of clinical implications. J Autoimmun 2015; 64: 26-41.
• 3. Megiorni F, Pizzuti A. HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci 2012; 19: 88.
• 4. Taylor AK, Lebwohl B, Snyder CL, Green PHR. Celiac Disease. 2008 Jul 3 [updated 2019 Jan 31]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023.Taylor AK, Lebwohl B, Snyder CL, Green PHR. Celiac Disease. 2008 Jul 3 [updated 2019 Jan 31]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023.
• 5. Megiorni F, Mora B, Bonamico M, Barbato M, Nenna R, Maiella G, et al. HLA-DQ and risk gradient for celiac disease. Hum Immunol 2009; 70: 55-9.
• 6. Siddiqui K, Uqaili AA, Rafiq M, Bhutto MA. Human leukocyte antigen (HLA)-DQ2 and -DQ8 haplotypes in celiac, celiac with type 1 diabetic, and celiac suspected pediatric cases. Medicine (Baltimore) 2021; 100: 24954.
• 7. Gnodi E, Meneveri R, Barisani D. Celiac disease: From genetics to epigenetics. World J Gastroenterol 2022; 28: 449-63.
• 8. Brown NK, Guandalini S, Semrad C, Kupfer SS. A Clinician’s Guide to Celiac Disease HLA Genetics. Am J Gastroenterol 2019; 114: 1587-92.
• 9. Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, et al. Coeliac disease. Nat Rev Dis Primers 2019; 5: 3.
• 10. Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-60.
• 11. Basturk A, Artan R, Yilmaz A. The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ. Prz Gastroenterol 2017; 12: 256-61.
• 12. Koskinen L, Romanos J, Kaukinen K, Mustalahti K, Korponay-Szabo I, Barisani D, et al. Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics 2009; 61: 247-56.
• 13. Vidales MC, Zubillaga P, Zubillaga I, Alfonso-Sánchez MA. Allele and haplotype frequencies for HLA class II (DQA1 and DQB1) loci in patients with celiac disease from Spain. Hum Immunol 2004; 65: 352-8.
• 14. Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. Am J Gastroenterol 2008; 103: 190-5.
• 15. Megiorni F, Mora B, Bonamico M, Barbato M, Montuori M, Viola F, et al. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol 2008; 103: 997-1003.
• 16. Schirru E, Jores RD, Cicotto L, Frau F, De Virgiliis S, Rossino R, et al. High frequency of low-risk human leukocyte antigen class II genotypes in latent celiac disease. Hum Immunol 2011; 72: 179-82.
• 17. Martínez-Ojinaga E, Fernández-Prieto M, Molina M, Polanco I, Urcelay E, Núñez C. Influence of HLA on clinical and analytical features of pediatric celiac disease. BMC Gastroenterol 2019; 19: 91.
• 18. Tolone C, Piccirillo M, Dolce P, Alfiero S, Arenella M, Sarnataro M, et al. Celiac disease in pediatric patients according to HLA genetic risk classes: a retrospective observational study. Ital J Pediatr 2021; 47: 107.